Identification and quantification of amyloid beta-related peptides in human plasma using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

DOI Web Site Web Site PubMed 4 Citations 17 References
  • KANEKO Naoki
    Koichi Tanaka Laboratory of Advanced Science and Technology, Shimadzu Corporation
  • YAMAMOTO Rie
    Koichi Tanaka Laboratory of Advanced Science and Technology, Shimadzu Corporation
  • SATO Taka-Aki
    Koichi Tanaka Laboratory of Advanced Science and Technology, Shimadzu Corporation Life Science Research Center, Shimadzu Corporation
  • TANAKA Koichi
    Koichi Tanaka Laboratory of Advanced Science and Technology, Shimadzu Corporation

Search this article

Abstract

Proteolytic processing of the amyloid precursor protein (APP) by β-secretase and γ-secretase leads to the generation and deposition of amyloid β (Aβ) in Alzheimer’s disease (AD). N-terminally or C-terminally truncated Aβ variants have been found in human cerebrospinal fluid and cultured cell media using immunoprecipitation and mass spectrometry. Unfortunately, the profile of plasma Aβ variants has not been revealed due to the difficulty of isolating Aβ from plasma. We present here for the first time studies of Aβ and related peptides in human plasma. Twenty-two Aβ-related peptides including novel peptides truncated before the β-secretase site were detected in human plasma and 20 of the peptides were identified by tandem mass spectrometry. Using an internal standard, we developed a quantitative assay for the Aβ-related peptides and demonstrated plasma dilution linearity and the precision required for their quantitation. The present method should enhance the understanding of APP processing and clearance in AD progression.

Journal

Citations (4)*help

See more

References(17)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top